Blog

How Alpha Analyst is redefining investment research. Insights, team perspectives, and the latest on building AI for finance.

Tesla Europe Registrations Are Falling: A Research Playbook

Tesla Europe Registrations Are Falling: A Research Playbook

How to verify the data, separate signal from noise, and track EV share shifts in 2026

QBTS Stock Pre-Market Rally: What Drove It and How to Verify the Catalyst

QBTS Stock Pre-Market Rally: What Drove It and How to Verify the Catalyst

A filing-first breakdown of D-Wave’s Jan 27 updates—and a checklist for separating headlines from fundamentals

NTLA stock jump: what the FDA clinical hold lift means

NTLA stock jump: what the FDA clinical hold lift means

A practical explainer of Intellia’s MAGNITUDE-2 update, the key risks to track next, and how to monitor trial and regulatory signals in Alpha Analyst

Amazon Fresh and Amazon Go Closures: Investor Research Playbook

Amazon Fresh and Amazon Go Closures: Investor Research Playbook

What the Whole Foods expansion signals, what to verify in filings, and how to monitor next steps in Alpha Analyst

Tesla brand value drop in 2025: What it signals for investors

Tesla brand value drop in 2025: What it signals for investors

How to turn a headline about brand perception into a repeatable monitoring workflow

IonQ–SkyWater deal: what was announced and how to research it

IonQ–SkyWater deal: what was announced and how to research it

A practical M&A-read checklist, key terms to track, and an Alpha Analyst workflow for staying ahead of the filings

Tesla autonomy and Robotaxi: how to research the “pivotal year” narrative

Tesla autonomy and Robotaxi: how to research the “pivotal year” narrative

Turn analyst commentary into a repeatable diligence workflow for TSLA’s self-driving roadmap, disclosures, and near-term catalysts

MNKD stock jump explained: Afrezza label update and what to watch next

MNKD stock jump explained: Afrezza label update and what to watch next

A practical catalyst breakdown for MannKind investors, plus a workflow to track FDA-driven moves in Alpha Analyst

IBRX Volatility: How to Read “Median OS Not Reached” Updates

IBRX Volatility: How to Read “Median OS Not Reached” Updates

A biotech catalyst checklist using ImmunityBio’s glioblastoma Phase 2 headline as a case study